[The action of vascular specific substances on the contractability of vascular muscle cells].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001808:Blood Vessels / Q000502:physiology*; D002339:Carotid Arteries / Q000502:physiology; D002417:Cattle; D004558:Electric Stimulation; D004594:Electrophysiology; D006168:Guinea Pigs; D006736:Horses; D008638:Mesenteric Arteries / Q000502:physiology; D009119:Muscle Contraction; D009129:Muscle Tonus; D009130:Muscle, Smooth / Q000166:cytology*; D009210:Myofibrils / Q000187:drug effects; D009928:Organ Specificity; D010455:Peptides / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013696:Temperature; D013997:Time Factors; D014020:Tissue Extracts
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010455:Peptides; D014020:Tissue Extracts; D010646:Phentolamine
Die Wirkung gefässeigener Stoffe auf die Kontraktilität der Gefässmuskelzellen.